Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
How do you approach postoperative radiation therapy in a patient with head and neck cancer who has high risk of recurrence in the setting of active epidermolysis bullosa?
Related Questions
Do you use any thyroid dose constraints for head neck radiation planning?
How do you consider the role of probiotics for mucositis mitigation in patients receiving head and neck radiotherapy?
How would you manage a presumed radiation induced sarcoma of the head and neck?
Would you modify your treatment approach for treating an HPV-positive head and neck cancer in a patient with symptomatic Sjogren's?
How do you approach a young patient with metastatic poorly differentiated thyroid cancer with rhabdoid/non-anaplastic features?
How should you approach treating curable laryngeal cancer with chemo-RT in a patient who had a myocardial infarction during treatment and requires CABG, given the cardiotoxicity of cisplatin and 5FU/carboplatin?
When would you consider larynx preservation in patients with T4N+ SCC of the larynx?
What would be your approach to the treatment of limited stage extrapulmonary small cell carcinoma of the nasopharynx with bilateral cervical lymphadenopathy?
Is there a role for bromhexine for thick secretions during/after head and neck RT?
What dose and fractionation would you use for Kaposi’s sarcoma of the tonsil post op?
